NCT04791852View on ClinicalTrials.gov

Potential Role of Donor-derived Cell-Free DNA as a Biomarker in Cardiac Allograft Vasculopathy

CompletedOBSERVATIONAL
Enrollment

94

Participants

Timeline

Start Date

January 10, 2019

Primary Completion Date

January 31, 2021

Study Completion Date

April 15, 2021

Conditions
Cardiac Allograft Vasculopathy
Interventions
DIAGNOSTIC_TEST

Donor-derived Cell Free DNA

We will compare ddcfDNA with coronary angiogram determined CAV grading, according to ISHTL2010 classification

Trial Locations (1)

28222

University Hospital Puerta de Hierro, Majadahonda

All Listed Sponsors
lead

Puerta de Hierro University Hospital

OTHER

NCT04791852 - Potential Role of Donor-derived Cell-Free DNA as a Biomarker in Cardiac Allograft Vasculopathy | Biotech Hunter | Biotech Hunter